VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 25 filers reported holding VASCULAR BIOGENICS LTD in Q1 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $45,000 | -10.0% | 37,500 | 0.0% | 0.00% | – |
| Q3 2019 | $50,000 | +2.0% | 37,500 | 0.0% | 0.00% | – |
| Q2 2019 | $49,000 | +44.1% | 37,500 | +66.7% | 0.00% | – |
| Q1 2019 | $34,000 | +54.5% | 22,500 | 0.0% | 0.00% | – |
| Q4 2018 | $22,000 | -40.5% | 22,500 | 0.0% | 0.00% | – |
| Q3 2018 | $37,000 | -41.3% | 22,500 | -17.7% | 0.00% | -100.0% |
| Q2 2018 | $63,000 | 0.0% | 27,330 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $63,000 | -66.3% | 27,330 | +3.8% | 0.00% | -50.0% |
| Q4 2017 | $187,000 | +34.5% | 26,330 | +15.3% | 0.00% | 0.0% |
| Q3 2017 | $139,000 | +36.3% | 22,830 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $102,000 | +41.7% | 22,830 | +75.6% | 0.00% | 0.0% |
| Q1 2017 | $72,000 | +200.0% | 13,000 | +160.0% | 0.00% | – |
| Q4 2016 | $24,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spectrum Planning & Advisory Services Inc. | 16,000 | $2,681 | 0.00% |
| Virtu Financial LLC | 37,424 | $6 | 0.00% |
| Affinity Capital Advisors, LLC | 22,265 | $3,729 | 0.00% |
| MORGAN STANLEY | 409,011 | $68,509 | 0.00% |
| HBK Sorce Advisory LLC | 20,575 | $3,447 | 0.00% |
| Bank of New York Mellon Corp | 39,000 | $6,533 | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 11,000 | $2 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 937 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 798 | $0 | 0.00% |